March marks Colorectal Cancer Awareness Month, a time to focus on one of the most preventable — and most treatable — forms of ...

Confirmed objective responses were observed at 8.6 and 10 mg/kg q3w, with a high overall disease control rate in late-line ...

OpEd: Colorectal cancer is now the leading cause of cancer death among adults under 50 and the only major cancer with ...

Broad endorsement for insurance-covered blood-based CRC screening (92%) suggests payer policy could materially influence ...

Colon cancer is appearing more often in younger adults, and many of those cases go undetected until the disease has already ...

Varseta-M Phase I CRC data, response rates, safety and registrational trial plans for 2027—read key insights now.

Shares of CytomX Therapeutics surged after the company reported positive data from an expanded Phase 1 trial of a colorectal cancer treatment, despite swinging to a loss in 2025. Shares were up 60% to ...

I was more scared to go on chemo than I was to find out I had cancer again.” Chemotherapy would have limited the amount of ...

Confirmed response rates in expansion cohorts of 32% at 10 mg/kg Q3W dose and 20% at 8.6 mg/kg Q3W -- Estimated progression free survival of ...

A new report found colorectal cancer diagnoses are climbing sharply among people younger than 50, raising concerns among ...

When Sheryl Levy collapsed in her home with excruciating abdominal pain, she believed she was suffering from a severe ...

March is Colorectal Cancer Awareness Month, a time to talk about prevention, screening, and early detection. According to the ...